scholarly journals The Effect of an Electronic Prescribing Policy for Opioids on Physician Prescribing Patterns Following Common Upper Extremity Procedures

Author(s):  
Monica M. Shoji ◽  
David N. Bernstein ◽  
Nelson Merchan ◽  
Kelly McFarlane ◽  
Carl M. Harper ◽  
...  
2016 ◽  
Vol 176 (8) ◽  
pp. 1114 ◽  
Author(s):  
Colette DeJong ◽  
Thomas Aguilar ◽  
Chien-Wen Tseng ◽  
Grace A. Lin ◽  
W. John Boscardin ◽  
...  

1993 ◽  
Vol 5 (1) ◽  
pp. 7-11 ◽  
Author(s):  
John Huszonek ◽  
Mantosh Dewan ◽  
Marvin Koss ◽  
William Hardoby ◽  
Abbas Ispahani

1973 ◽  
Vol 3 (4) ◽  
pp. 389-402 ◽  
Author(s):  
C. Joseph Stetler

Promotional efforts directed to the health professions by pharmaceutical manufacturers, and their alleged association with excessive prescribing and drug abuse are the subject of this paper. The paper contends that claims to the effect that legitimate drug prescribing patterns and promotional efforts merely mirror—or even may cause—drug abuse are not factually supported. Assertions to the effect that physicians rely primarily on advertising in making prescribing decisions are not borne out by studies of the various factors which bear upon those decisions, the paper points out. It describes the extent of prescription drug promotion, and utilization and notes that physician prescribing of psychoactive drugs has lagged behind overall prescription growth trends, in contrast to the accelerating misuse and abuse of this class of medications in the community at large.


2002 ◽  
Vol 5 (3) ◽  
pp. 264
Author(s):  
AM Rahman ◽  
J Feldhaus ◽  
L Lawrence ◽  
H Rappaport

1976 ◽  
Vol 10 (2) ◽  
pp. p84-p90
Author(s):  
Norman L. Trabert ◽  
Jack Froom ◽  
Peter Elias ◽  
John P. Morgan

Medical Care ◽  
1994 ◽  
Vol 32 (5) ◽  
pp. 436-446 ◽  
Author(s):  
Gonzalo Guti??rrez ◽  
H??ctor Guiscafr?? ◽  
Mario Bronfman ◽  
Julia Walsh ◽  
Homero Mart??nez ◽  
...  

1980 ◽  
Vol 14 (4) ◽  
pp. 280-283
Author(s):  
Thomas R. Adams ◽  
William J. Murray ◽  
J. Heyward Hull

Patient exposure to potential anticoagulant drug interactions was identified by computerized drug-therapy surveillance, as part of a peer-review program. To evaluate the response of clinicians provided with data on the potential drug interactions, 119 “exposed” patients were randomly divided and assigned to study or control groups. Physicians prescribing for the 60 study patients were informed of the potential problem by letter and were furnished with information on the drug interaction, while the 59 control patients were only monitored. Physicians provided with the information made statistically more changes in drug therapy than those not informed ( p < 0.05). Over 75 percent of study-patient physicians responding to a questionnaire accompanying the drug interaction data indicated that the service was useful and should be expanded to other drugs. Application of methods similar to that used in this study should offer drug utilization review committees an effective approach to improving drug therapy.


Sign in / Sign up

Export Citation Format

Share Document